Displaying 10 out of 136 results

  1. New Content Item

    Mersana Therapeutics cancer drug trial on partial hold by FDA

  2. New Content Item

    CTI Biopharma's cancer drug fails late-stage trial

  3. FILE PHOTO: A man walks past a sign at an AstraZeneca site in Macclesfield

    AstraZeneca wins speedy approvals for cancer drugs in Japan

    AstraZeneca has won rapid regulatory approval for new uses of two of its important cancer drugs in Japan, less than six months after the first ...
  4. FILE PHOTO: Logo of Swiss drugmaker Roche is seen at its headquarters in Basel

    Roche highlights Tecentriq results in triple negative breast cancer

    Swiss drugmaker Roche said on Monday that a trial showed its immunotherapy Tecentriq plus the chemotherapy Abraxane significantly reduced the risk ...
  5. New Content Item

    Puma Biotech gets EU panel nod for breast cancer drug

  6. A view shows the U.S. Food and Drug Administration headquarters in Silver Spring

    FDA approves Array BioPharma's melanoma combo treatment

    The U.S. Food and Drug Administration (FDA) said on Wednesday it had approved Array BioPharma Inc's oral combination treatment for use in patients ...
  7. FILE PHOTO: A sign is seen at an AstraZeneca site in Macclesfield

    AstraZeneca, Merck eye US$1 billion boost from cancer drug success

    AstraZeneca's oncology business received a boost on Wednesday as results of a clinical trial showed its drug Lynparza helped women with ovarian ...
  8. New Content Item

    Puma Biotech says Europe likely to approve breast cancer drug